Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis

The aim of this editorial is to evaluate the evidence for using pimavanserin for the treatment of Parkinson's disease psychosis (PDP) from randomized controlled trials (RCTs). We only identified two published trials that evaluated the use of pimavanserin among individuals with PDP. Both studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Tampi, Rajesh R, Tampi, Deena J, Young, Juan J, Balachandran, Silpa, Hoq, Rakin A, Manikkara, Geetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560499/
https://www.ncbi.nlm.nih.gov/pubmed/31211112
http://dx.doi.org/10.5498/wjp.v9.i3.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560499/
https://www.ncbi.nlm.nih.gov/pubmed/31211112
http://dx.doi.org/10.5498/wjp.v9.i3.47

Ejemplares similares